Legal Representation
Attorney
Nicholas J. Gingo
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 16, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 16, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 21, 2025 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | Loading... |
| Oct 1, 2025 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Nov 21, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 1, 2025 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED | Loading... |
| Apr 26, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 25, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 25, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 29, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 29, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 29, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 29, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 29, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 29, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 29, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Apr 29, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Apr 29, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Apr 3, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 27, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 27, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 26, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jan 23, 2024 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Jan 23, 2024 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Jan 23, 2024 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jan 10, 2024 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jun 2, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 2, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 2, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 1, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 1, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 31, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Mar 6, 2023 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Mar 6, 2023 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Mar 6, 2023 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Aug 4, 2022 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Aug 4, 2022 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Aug 4, 2022 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 28, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 28, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 28, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 26, 2022 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jul 20, 2022 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Jul 20, 2022 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Jul 20, 2022 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jun 24, 2022 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for use in the treatment of kidney diseases, liver diseases, and inflammatory bowel diseases and pulmonary diseases namely coughs and lung cancer
Classification
International Classes
005